# RxSight (RXST) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/RXST
## Company Profile
- Ticker: RXST
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: MedTech
## Stock Data
- Close: 4.85 USD
- Market cap: 204499248.46 USD
- Last updated: 2026-10-08
## Business Overview
### Adjustable Cataract Lenses
RxSight is an ophthalmic medical-device company focused on customized vision after cataract surgery.
### Light Adjustable Lens System
The system combines an implantable Light Adjustable Lens with a Light Delivery Device. After surgery, physicians use ultraviolet light treatments to modify the lens and refine the patient's refractive outcome.
### Installed-Base Model
RxSight sells capital equipment to eye-care practices and generates recurring revenue from lenses and procedure-related accessories used across the installed base.
## Why The Stock Is Moving

As of Oct 8, 2026, RXST closed up 1.04% at $4.85. No new same-company headline was identified in the current news window.

## Recent News
- 2026-08-26 20:15 EST — [RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference](https://biopharmsignal.com/news/RXST/rxsight-inc-to-participate-in-the-wells-fargo-healthcare-conference-a0d23f9c) — Source: RxSight
- 2026-08-05 20:05 EST — [RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook](https://biopharmsignal.com/news/RXST/rxsight-inc-reports-second-quarter-2026-results-and-provides-update-on-2026-outl-7fbe81a1) — Source: RxSight
- 2026-07-26 20:00 EST — [RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules](https://biopharmsignal.com/news/RXST/rxsight-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-54fac423) — Source: RxSight
- 2026-07-15 20:15 EST — [RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer](https://biopharmsignal.com/news/RXST/rxsight-announces-appointments-of-aziz-mottiwala-as-chief-executive-officer-and--e8d69a0c) — Source: RxSight
- 2026-07-06 20:16 EST — [Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs](https://biopharmsignal.com/news/RXST/alcon-and-rxsight-announce-collaboration-to-develop-adjustable-pciols-d11bd105) — Source: RxSight